| |
| Issue |
Title |
| |
| Vol 11, No 1 (2021) |
Factors affecting overall survival in ductal adenocarcinoma of the pancreatic head. Experience of one center |
Abstract
PDF (Rus)
|
|
D. M. Kuchin, Ya. I. Kolesnik, H. G. Torgomyan, V. E. Zagainov |
| |
| Vol 11, No 1 (2021) |
Dynamics of changes in type 1 and 2 insulinlike growth factors in the blood of patients with oral squamous cell cancer after targeted therapy with cetuximab |
Abstract
PDF (Rus)
|
|
A. A. Lyanova, L. Yu. Vladimirova, E. M. Frantsiyants, I. V. Neskubina, M. A. Engibaryan, N. A. Abramova, I. L. Popova, M. A. Teplyakova, N. M. Tikhanovskaya, V. S. Myagkova, K. A. Novoselova, L. A. Ryadinskaya, F. V. Alieva |
| |
| Vol 9, No 3 (2019) |
Phase 1b multicenter study of the safety and efficacy of stereotactic body radiation therapy for extracranial renal cell carcinoma metastases in combination with tyrosine kinase inhibitors or checkpoint inhibitors (VOLGA STUDY). |
Abstract
PDF (Rus)
|
|
N. V. Dengina, T. Mitin, S. V. Gamayunov, S. Safina, Yu. M. Kreinina, I. V. Tsimafeyeu |
| |
| Vol 9, No 3 (2019) |
The predictive value of biological characteristics of residual tumors after neoadjuvant chemotherapy in early triple-negative breast cancer |
Abstract
PDF (Rus)
|
|
M. A. Frolova, M. B. Stenina, E. V. Glazkova, E. O. Ignatova, S. F. Menshikova, А. V. Petrovsky, O. V. Krokhina, Y. V. Vishnevskaya, S. A. Tjulandin |
| |
| Vol 9, No 3 (2019) |
Clinical, morphological and molecular predictors of metastatic regional lymph node involvement in breast cancer patients |
Abstract
PDF (Rus)
|
|
Yu. A. Dergunova, V. V. Rodionov, V. V. Kometova |
| |
| Vol 9, No 3 (2019) |
Toxicity and efficacy of gemcitabine plus nab-paclitaxel (paclitaxel + albumin) in a Russian patient population: results of a multicenter retrospective study |
Abstract
PDF (Rus)
|
|
I. A. Pokataev, M. A. Lyadova, М. Yu. Fedyanin, A. A. Tryakin, V. A. Chubenko, F. V. Moiseenko, L. A. Zagorskaya, М. L. Stepanova, A. V. Androsova, D. A. Nosov, N. V. Karpova, О. I. Kit, L. Yu. Vladimirova, I. L. Popova, A. V. Belonogov, D. М. Ponomarenko, D. Yu. Yukalchuk, V. Е. Shikina, N. V. Ivanova, А. I. Khasanova, А. D. Kruglov, I. Yu. Stradaeva, А. S. Perepletova, V. М. Filippova, N. L. Buzova, О. V. Khavaeva, Kh. S. Musaeva, А. Yu. Goryainova, О. V. Romanchuk, I. Sh. Tespizhek, S. А. Tyulyandin |
| |
| Vol 9, No 3 (2019) |
Treatment outcomes in patients with febrile neutropenia progressing to a critical condition |
Abstract
PDF (Rus)
|
|
G. S. Yunaev, I. A. Kurmukov |
| |
| Vol 9, No 3 (2019) |
A new nutriceutical to improve tolerance of adjuvant chemotherapy |
Abstract
PDF (Rus)
|
|
D. R. Kaydarova, M. V. Kopp, A. S. Mochalova, V. S. Pokrovsky, Zh. M. Akimzhanova, R. Z. Abdrakhmanov, E. V. Bilan, A. V. Byakhov, S. N. Gurov, I. A. Koroleva, S. S. Povaga, M. V. Raygorodsky, E. M. Saydasheva, E. V. Shilova, B. Z. Dzhafarova, I. V. Turova, Yu. A. Petrovskaya, F. I. Petrovsky |
| |
| Vol 9, No 3 (2019) |
Current approaches to the treatment of advanced ovarian cancer using PET / CT-guided hyperthermic chemoperfusion. A clinical experience |
Abstract
PDF (Rus)
|
|
V. V. Saevets, A. V. Taratonov, A. V. Privalov, A. V. Vazhenin, E. A. Ulrikh |
| |
| Vol 7, No 4 (2017) |
ERIBULIN MESYLATE: OUR EXPERIENCE IN A REAL-LIFE CLINICAL SETTING |
Abstract
PDF (Rus)
|
|
D. V. Filonenko, A. V. Belonogov |
| |
| Vol 7, No 4 (2017) |
EVALUATION OF EFFICACY AND TOXICITY OF NEOADJUVANT ALTERNATING CHEMOTHERAPY IN PATIENTS WITH LOCALLY ADVANCED TRIPLE NEGATIVE BREAST CANCER |
Abstract
PDF (Rus)
|
|
E. O. Ignatova, M. A. Frolova, M. B. Stenina, E. V. Glazkova, O. V. Krokhina, A. B. Petrovsky, C. А. Tjulandin |
| |
| Vol 7, No 4 (2017) |
THE RESULTS OF A STUDY OF CHEMOTHERAPY WITH BEVACIZUMAB, OXALIPLATIN AND PACLITAXEL IN PATIENTS WITH METASTATIC TRIPLE NEGATIVE BREAST CANCER |
Abstract
PDF (Rus)
|
|
O. V. Smirnova |
| |
| No 3 (2017) |
The results of I-125 brachytherapy in patients of moderate-risk prostate cancer |
Abstract
PDF (Rus)
|
|
A. V. Petrovsky, V. A. Amosova, V. A. Chernyaev, D. E. Avtomonov, B. V. Buharkin, V. N. Sholokhov, D. A. Roshin, M. I. Nechushkin, V. B. Matveev |
| |
| No 3 (2017) |
Efficacy and safety of eribulin in various subtypes of breast cancer: data from real clinical practice in Russia |
Abstract
PDF (Rus)
|
|
L. V. Manzyuk, E. I. Kovalenko, V. A. Gorbunova, L. V. Bolotina, T. Y. Semiglazova, L. A. Zhilyaeva, Y. A. Mishina, D. M. Ponomarenko, V. E. Goldberg, N. O. Popova, E. V. Karabina, G. Z. Mukhametshina, A. I. Khasanova, S. Z. Safina, M. V. Shaidorov, L. Y. Vladimirova, I. S. Mitashok, E. P. Prokofieva, I. V. Evstigneeva, I. I. Andreyashkina, N. A. Abramova, I. L. Popova, A. A. Teterich, E A. Gaisina, V. A. Chubenko, S. V. Limareva, N. M. Tikhanovskaya, A. E. Storozhakova, N. Y. Samaneva, Y. V. Svetitskaya, T. A. Snezhko, E. A. Kalabanova, A. Y. Povyshev, I. V. Yudina, L. V. Vorotilina, T. V. Andreeva, G. C. Tumanyan, A. E. Kozyakov, L. A. Gilmutdinova |
| |
| No 3 (2017) |
Modern tactics of treatment of tumor pericarditis |
Abstract
PDF (Rus)
|
|
K. S. Titov, M. V. Kiselevsk |
| |
| No 2 (2017) |
Assessment of influence of two regimens of intravenous administration of a klodronat on dynamics of a pain syndrome and quality of life of patients with breast cancer metastasises in skeleton bones |
Abstract
PDF (Rus)
|
|
V. G. Moskin, L. M. Kogoniya |
| |
| No 2 (2017) |
Modern tactics of treatment of malignant glyom of the brain and the case of the complete answer of the tumor on the background of the long-term reception of bevacizumab |
Abstract
PDF (Rus)
|
|
F. F. Mufazalov, R. R. Abbasova, N. A. Mufazalova, O. V. Goncharova, L. Kh. Safina, L. F. Mufazalova |
| |
| No 2 (2017) |
Reproductive function in patients with malignant ovarian germ cell tumours |
Abstract
PDF (Rus)
|
|
D. A. Chekini, A. A. Tryakin, M. Y. Fedyanin, K. I. Zhordania, I. A. Pokataev, A. A. Bulanov, T. I. Zakharova, S. A. Tjulandin |
| |
| No 2 (2017) |
Chemotherapy in combination with bevacizumab in breast cancer. Results of the observational study in daily clinical practice |
Abstract
PDF (Rus)
|
|
E. I. Kovalenko, L. I. Osmanova, I. B. Kononenko, E. F. Abdullaeva, E. V. Artamonova, L. V. Manzyuk |
| |
| No 4 (2016) |
LAPAROSCOPIC HUSTERECTOMY WITH A PELVIC LYMPHADENECTOMY, AS ALTERNATIVE LAPAROTOMY AT ENDOMETRIUM CANCER SURGERY |
Abstract
PDF (Rus)
|
|
S. V. Anpilogov, A. S. Shevchuk, E. G. Novikova |
| |
| No 4 (2016) |
EVALUATION OF EFFICACY AND TOXICITY OF NEOADJUVANT CHEMOTHERAPY WITH DOSE-DENSE DOXORUBICIN, CISPLATIN, AND PACLITAXEL IN PATIENTS WITH EARLY TRIPLE-NEGATIVE BREAST CANCER |
Abstract
PDF (Rus)
|
|
E. O. Ignatova, M. A. Frolova, A. B. Petrovsky, M. B. Stenina, E. V. Glazkova, O. V. Krokhina, C. A. Tjulandin |
| |
| No 4 (2016) |
THE COMPARISON OF THE THERAPEUTIC EQUIVALENCE OF OXALIPLATINRONC® (BRANCH “NAUKOPROFI” OF N.N. BLOKHIN RCRC) AND ELOXATIN® (AVENTIS PHARMA LTD, GREAT BRITAIN) IN MFOLFOX6 COMBINATION AS A FIRST LINE OF CHEMOTHERAPY IN PATIENTS WITH METASTATIC COLORECTAL CANCER |
Abstract
PDF (Rus)
|
|
A. А. Kolomeytseva, S. V. Kopachevskaia, N. F. Orel, V. A. Gorbunova, T. Y. Eskina, M. Y. Fedyanin, L. V. Manzyuk, A. V. Snegovoy, L. S. Scriabina, G. Z. Mukhametshina, A. S. Odintsova, E. V. Trusilova, F. H. Mukhametgaleeva, O. V. Sehina, Y. V. Vakhabova, N. V. Dobrova, E. V. Chtrnoglazova |
| |
| No 4 (2016) |
IMMUNE-MEDIATED ADVERSE EVENTS ASSOCIATED WITH IMMUNE CHECKPOINT INHIBITORS THERAPY |
Abstract
PDF (Rus)
|
|
E. V. Reutova, K. P. Laktionov, V. V. Breder, K. A. Sarantseva, M. A. Okruzhnova, M. V. Peregudova |
| |
| No 4 (2016) |
MAIN INDICATORS OF ONCOLOGY SERVICE MOSCOW REGION FOR 2015 |
Abstract
PDF (Rus)
|
|
S. N. Minakov |
| |
| No 4 (2016) |
CLINICAL CASE GRANULAR CELL TUMOR OF BREAST |
Abstract
PDF (Rus)
|
|
A. S. Zotov, A. A. Samusieva, M. V. Dyatel |
| |
| No 3 (2016) |
Epidermal growth factor receptor as target of moleculartargeted therapy in patients with primary non-small cell lung cancer |
Abstract
PDF (Rus)
|
|
D. D. SAKAEVA, M. G. GORDIEV |
| |
| No 3 (2016) |
Surgical technology catheterization hepatic arteri under selective intra-arterial chemotherapy |
Abstract
PDF (Rus)
|
|
R. V. ISHCHENKO, I. N. DZHANSYZ, I. V. FESAK |
| |
| No 3 (2016) |
Sentinel lymph nodes biopsy in early breast cancer and melanoma patients using “Tehnefit 99mTc” radioactive colloid technetium 99mTc |
Abstract
PDF (Rus)
|
|
A. V. ERMAKOV, A. D. ZIKIRYAHODZHAEV, T. N. LAZUTINA, A. V. LEONTYEV, N. N. VOLCHENKO, M. M. BELYAKOV, A. D. KAPRIN, A. A. KOSTIN |
| |
| No 1 (2016) |
EXPERIENCE OF HORMONE DEPENDENT PROSTATE CANCER TREATMENT BY LUTEINISING HORMONE-RELEASING HORMONE ANTAGONIST DEGARELIX |
Abstract
PDF (Rus)
|
|
G. P. Kolesnikov, I. G. Rusakov, A. A. Gritskevich, S. V. Mishugin, V. I. Shirokorad, N. V. Kirdakova, D. G. Sokov, A. A. Vorontsova |
| |
| No 1 (2016) |
THE INFRAHYOID MUSCULOCUTANEOUS FLAP FOR THE ORAL CAVITY RECONSTRUCTION |
Abstract
PDF (Rus)
|
|
А. V. Karpenko, R. R. Sibgatullin, A. A. Boyko, N. S. Chumanikchina, N. V. Boyko, L. D. Roman, A. V. Byakhov, E. N. Belova, I. I. Maleshin |
| |
| 1 - 30 of 30 Items |
|
